Myeloid Cells Targeting Therapeutics Market, Global Outlook and Forecast 2022-2028

May 2022 | 69 pages | ID: M5D8C1B19C4FEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Myeloid Cells Targeting Therapeutics in Global, including the following market information:

Global Myeloid Cells Targeting Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Myeloid Cells Targeting Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Intravenous Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Myeloid Cells Targeting Therapeutics include ChemoCentryx, Daiichi Sankyo, Gilead Sciences, Janssen Biotech, Roche, Pfizer, GlaxoSmithKline, Macrophage Pharma and Enlivex, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Myeloid Cells Targeting Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Myeloid Cells Targeting Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Myeloid Cells Targeting Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Intravenous Injection
• Oral

Global Myeloid Cells Targeting Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Myeloid Cells Targeting Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Oncological Disorders
• Rare Disorders

Global Myeloid Cells Targeting Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Myeloid Cells Targeting Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Myeloid Cells Targeting Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Myeloid Cells Targeting Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• ChemoCentryx
• Daiichi Sankyo
• Gilead Sciences
• Janssen Biotech
• Roche
• Pfizer
• GlaxoSmithKline
• Macrophage Pharma
• Enlivex
• Immune-Onc Therapeutics
• Infinity Pharmaceuticals
• AstraZeneca

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Myeloid Cells Targeting Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Myeloid Cells Targeting Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL MYELOID CELLS TARGETING THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Myeloid Cells Targeting Therapeutics Market Size: 2021 VS 2028
2.2 Global Myeloid Cells Targeting Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Myeloid Cells Targeting Therapeutics Players in Global Market
3.2 Top Global Myeloid Cells Targeting Therapeutics Companies Ranked by Revenue
3.3 Global Myeloid Cells Targeting Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Myeloid Cells Targeting Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Myeloid Cells Targeting Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Myeloid Cells Targeting Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Myeloid Cells Targeting Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Myeloid Cells Targeting Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Myeloid Cells Targeting Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Intravenous Injection
  4.1.3 Oral
4.2 By Type - Global Myeloid Cells Targeting Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Myeloid Cells Targeting Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Myeloid Cells Targeting Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Myeloid Cells Targeting Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Myeloid Cells Targeting Therapeutics Market Size, 2021 & 2028
  5.1.2 Oncological Disorders
  5.1.3 Rare Disorders
5.2 By Application - Global Myeloid Cells Targeting Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Myeloid Cells Targeting Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Myeloid Cells Targeting Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Myeloid Cells Targeting Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Myeloid Cells Targeting Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Myeloid Cells Targeting Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Myeloid Cells Targeting Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Myeloid Cells Targeting Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Myeloid Cells Targeting Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Myeloid Cells Targeting Therapeutics Revenue, 2017-2028
  6.3.2 US Myeloid Cells Targeting Therapeutics Market Size, 2017-2028
  6.3.3 Canada Myeloid Cells Targeting Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Myeloid Cells Targeting Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Myeloid Cells Targeting Therapeutics Revenue, 2017-2028
  6.4.2 Germany Myeloid Cells Targeting Therapeutics Market Size, 2017-2028
  6.4.3 France Myeloid Cells Targeting Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Myeloid Cells Targeting Therapeutics Market Size, 2017-2028
  6.4.5 Italy Myeloid Cells Targeting Therapeutics Market Size, 2017-2028
  6.4.6 Russia Myeloid Cells Targeting Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Myeloid Cells Targeting Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Myeloid Cells Targeting Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Myeloid Cells Targeting Therapeutics Revenue, 2017-2028
  6.5.2 China Myeloid Cells Targeting Therapeutics Market Size, 2017-2028
  6.5.3 Japan Myeloid Cells Targeting Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Myeloid Cells Targeting Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Myeloid Cells Targeting Therapeutics Market Size, 2017-2028
  6.5.6 India Myeloid Cells Targeting Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Myeloid Cells Targeting Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Myeloid Cells Targeting Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Myeloid Cells Targeting Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Myeloid Cells Targeting Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Myeloid Cells Targeting Therapeutics Market Size, 2017-2028
  6.7.3 Israel Myeloid Cells Targeting Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Myeloid Cells Targeting Therapeutics Market Size, 2017-2028
  6.7.5 UAE Myeloid Cells Targeting Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 ChemoCentryx
  7.1.1 ChemoCentryx Corporate Summary
  7.1.2 ChemoCentryx Business Overview
  7.1.3 ChemoCentryx Myeloid Cells Targeting Therapeutics Major Product Offerings
  7.1.4 ChemoCentryx Myeloid Cells Targeting Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 ChemoCentryx Key News
7.2 Daiichi Sankyo
  7.2.1 Daiichi Sankyo Corporate Summary
  7.2.2 Daiichi Sankyo Business Overview
  7.2.3 Daiichi Sankyo Myeloid Cells Targeting Therapeutics Major Product Offerings
  7.2.4 Daiichi Sankyo Myeloid Cells Targeting Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Daiichi Sankyo Key News
7.3 Gilead Sciences
  7.3.1 Gilead Sciences Corporate Summary
  7.3.2 Gilead Sciences Business Overview
  7.3.3 Gilead Sciences Myeloid Cells Targeting Therapeutics Major Product Offerings
  7.3.4 Gilead Sciences Myeloid Cells Targeting Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Gilead Sciences Key News
7.4 Janssen Biotech
  7.4.1 Janssen Biotech Corporate Summary
  7.4.2 Janssen Biotech Business Overview
  7.4.3 Janssen Biotech Myeloid Cells Targeting Therapeutics Major Product Offerings
  7.4.4 Janssen Biotech Myeloid Cells Targeting Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Janssen Biotech Key News
7.5 Roche
  7.5.1 Roche Corporate Summary
  7.5.2 Roche Business Overview
  7.5.3 Roche Myeloid Cells Targeting Therapeutics Major Product Offerings
  7.5.4 Roche Myeloid Cells Targeting Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Roche Key News
7.6 Pfizer
  7.6.1 Pfizer Corporate Summary
  7.6.2 Pfizer Business Overview
  7.6.3 Pfizer Myeloid Cells Targeting Therapeutics Major Product Offerings
  7.6.4 Pfizer Myeloid Cells Targeting Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 Pfizer Key News
7.7 GlaxoSmithKline
  7.7.1 GlaxoSmithKline Corporate Summary
  7.7.2 GlaxoSmithKline Business Overview
  7.7.3 GlaxoSmithKline Myeloid Cells Targeting Therapeutics Major Product Offerings
  7.7.4 GlaxoSmithKline Myeloid Cells Targeting Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 GlaxoSmithKline Key News
7.8 Macrophage Pharma
  7.8.1 Macrophage Pharma Corporate Summary
  7.8.2 Macrophage Pharma Business Overview
  7.8.3 Macrophage Pharma Myeloid Cells Targeting Therapeutics Major Product Offerings
  7.8.4 Macrophage Pharma Myeloid Cells Targeting Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 Macrophage Pharma Key News
7.9 Enlivex
  7.9.1 Enlivex Corporate Summary
  7.9.2 Enlivex Business Overview
  7.9.3 Enlivex Myeloid Cells Targeting Therapeutics Major Product Offerings
  7.9.4 Enlivex Myeloid Cells Targeting Therapeutics Revenue in Global Market (2017-2022)
  7.9.5 Enlivex Key News
7.10 Immune-Onc Therapeutics
  7.10.1 Immune-Onc Therapeutics Corporate Summary
  7.10.2 Immune-Onc Therapeutics Business Overview
  7.10.3 Immune-Onc Therapeutics Myeloid Cells Targeting Therapeutics Major Product Offerings
  7.10.4 Immune-Onc Therapeutics Myeloid Cells Targeting Therapeutics Revenue in Global Market (2017-2022)
  7.10.5 Immune-Onc Therapeutics Key News
7.11 Infinity Pharmaceuticals
  7.11.1 Infinity Pharmaceuticals Corporate Summary
  7.11.2 Infinity Pharmaceuticals Business Overview
  7.11.3 Infinity Pharmaceuticals Myeloid Cells Targeting Therapeutics Major Product Offerings
  7.11.4 Infinity Pharmaceuticals Myeloid Cells Targeting Therapeutics Revenue in Global Market (2017-2022)
  7.11.5 Infinity Pharmaceuticals Key News
7.12 AstraZeneca
  7.12.1 AstraZeneca Corporate Summary
  7.12.2 AstraZeneca Business Overview
  7.12.3 AstraZeneca Myeloid Cells Targeting Therapeutics Major Product Offerings
  7.12.4 AstraZeneca Myeloid Cells Targeting Therapeutics Revenue in Global Market (2017-2022)
  7.12.5 AstraZeneca Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Myeloid Cells Targeting Therapeutics Market Opportunities & Trends in Global Market
Table 2. Myeloid Cells Targeting Therapeutics Market Drivers in Global Market
Table 3. Myeloid Cells Targeting Therapeutics Market Restraints in Global Market
Table 4. Key Players of Myeloid Cells Targeting Therapeutics in Global Market
Table 5. Top Myeloid Cells Targeting Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Myeloid Cells Targeting Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Myeloid Cells Targeting Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Myeloid Cells Targeting Therapeutics Product Type
Table 9. List of Global Tier 1 Myeloid Cells Targeting Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Myeloid Cells Targeting Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Myeloid Cells Targeting Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Myeloid Cells Targeting Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Myeloid Cells Targeting Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Myeloid Cells Targeting Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Myeloid Cells Targeting Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Myeloid Cells Targeting Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Myeloid Cells Targeting Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Myeloid Cells Targeting Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Myeloid Cells Targeting Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Myeloid Cells Targeting Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Myeloid Cells Targeting Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Myeloid Cells Targeting Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Myeloid Cells Targeting Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Myeloid Cells Targeting Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Myeloid Cells Targeting Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Myeloid Cells Targeting Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Myeloid Cells Targeting Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Myeloid Cells Targeting Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Myeloid Cells Targeting Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. ChemoCentryx Corporate Summary
Table 31. ChemoCentryx Myeloid Cells Targeting Therapeutics Product Offerings
Table 32. ChemoCentryx Myeloid Cells Targeting Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Daiichi Sankyo Corporate Summary
Table 34. Daiichi Sankyo Myeloid Cells Targeting Therapeutics Product Offerings
Table 35. Daiichi Sankyo Myeloid Cells Targeting Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Gilead Sciences Corporate Summary
Table 37. Gilead Sciences Myeloid Cells Targeting Therapeutics Product Offerings
Table 38. Gilead Sciences Myeloid Cells Targeting Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Janssen Biotech Corporate Summary
Table 40. Janssen Biotech Myeloid Cells Targeting Therapeutics Product Offerings
Table 41. Janssen Biotech Myeloid Cells Targeting Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Roche Corporate Summary
Table 43. Roche Myeloid Cells Targeting Therapeutics Product Offerings
Table 44. Roche Myeloid Cells Targeting Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Pfizer Corporate Summary
Table 46. Pfizer Myeloid Cells Targeting Therapeutics Product Offerings
Table 47. Pfizer Myeloid Cells Targeting Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. GlaxoSmithKline Corporate Summary
Table 49. GlaxoSmithKline Myeloid Cells Targeting Therapeutics Product Offerings
Table 50. GlaxoSmithKline Myeloid Cells Targeting Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Macrophage Pharma Corporate Summary
Table 52. Macrophage Pharma Myeloid Cells Targeting Therapeutics Product Offerings
Table 53. Macrophage Pharma Myeloid Cells Targeting Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Enlivex Corporate Summary
Table 55. Enlivex Myeloid Cells Targeting Therapeutics Product Offerings
Table 56. Enlivex Myeloid Cells Targeting Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Immune-Onc Therapeutics Corporate Summary
Table 58. Immune-Onc Therapeutics Myeloid Cells Targeting Therapeutics Product Offerings
Table 59. Immune-Onc Therapeutics Myeloid Cells Targeting Therapeutics Revenue (US$, Mn), (2017-2022)
Table 60. Infinity Pharmaceuticals Corporate Summary
Table 61. Infinity Pharmaceuticals Myeloid Cells Targeting Therapeutics Product Offerings
Table 62. Infinity Pharmaceuticals Myeloid Cells Targeting Therapeutics Revenue (US$, Mn), (2017-2022)
Table 63. AstraZeneca Corporate Summary
Table 64. AstraZeneca Myeloid Cells Targeting Therapeutics Product Offerings
Table 65. AstraZeneca Myeloid Cells Targeting Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Myeloid Cells Targeting Therapeutics Segment by Type in 2021
Figure 2. Myeloid Cells Targeting Therapeutics Segment by Application in 2021
Figure 3. Global Myeloid Cells Targeting Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Myeloid Cells Targeting Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Myeloid Cells Targeting Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Myeloid Cells Targeting Therapeutics Revenue in 2021
Figure 8. By Type - Global Myeloid Cells Targeting Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Myeloid Cells Targeting Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Myeloid Cells Targeting Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Myeloid Cells Targeting Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Myeloid Cells Targeting Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Myeloid Cells Targeting Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Myeloid Cells Targeting Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Myeloid Cells Targeting Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Myeloid Cells Targeting Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Myeloid Cells Targeting Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Myeloid Cells Targeting Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Myeloid Cells Targeting Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Myeloid Cells Targeting Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Myeloid Cells Targeting Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Myeloid Cells Targeting Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Myeloid Cells Targeting Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Myeloid Cells Targeting Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Myeloid Cells Targeting Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Myeloid Cells Targeting Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Myeloid Cells Targeting Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Myeloid Cells Targeting Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Myeloid Cells Targeting Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Myeloid Cells Targeting Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Myeloid Cells Targeting Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Myeloid Cells Targeting Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Myeloid Cells Targeting Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Myeloid Cells Targeting Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Myeloid Cells Targeting Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Myeloid Cells Targeting Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. ChemoCentryx Myeloid Cells Targeting Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Daiichi Sankyo Myeloid Cells Targeting Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Gilead Sciences Myeloid Cells Targeting Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Janssen Biotech Myeloid Cells Targeting Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Roche Myeloid Cells Targeting Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Pfizer Myeloid Cells Targeting Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. GlaxoSmithKline Myeloid Cells Targeting Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Macrophage Pharma Myeloid Cells Targeting Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Enlivex Myeloid Cells Targeting Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Immune-Onc Therapeutics Myeloid Cells Targeting Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Infinity Pharmaceuticals Myeloid Cells Targeting Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. AstraZeneca Myeloid Cells Targeting Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)